Latest News

Latest News

News from the World Hepatitis Alliance

Welcoming new members to the World Hepatitis Alliance

17 Jul 2015 Bridie Taylor

Over the past few months we have welcomed a surge of new members to the World Hepatitis Alliance and we are proud to now have 216 member groups in 80...

2 weeks until World Hepatitis Day!

14 Jul 2015 Bridie Taylor

July 28 is now fast approaching and it’s set to be the biggest World Hepatitis Day yet! But we need your support to ensure we reach as many people as...

Calling for greater commitment to the fight against hepatitis at the World Health Assembly

28 May 2015 Bridie Taylor

The 68th session of the World Health Assembly (WHA68) took place in Geneva from 18th-26th May. On 25th May, the World Hepatitis Alliance was invited...

Supporting the launch of guidelines and policies to address viral hepatitis

1 Apr 2015 Bridie Taylor

WHO Injection Safety policy Every year 1.7 million people are infected with hepatitis B through unsafe injection and 315,000 with hepatitis C. Yet up...

Working closely with WHO to develop a global strategy

1 Apr 2015 Bridie Taylor

WHO Strategic and Technical Advisory Committee for hepatitis (STAC-HEP) meeting, Geneva, Switzerland, 19 – 20 February As part of an expert advisory...

Highlighting the importance of patient advocacy at international conferences

31 Mar 2015 Bridie Taylor

24th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Istanbul, Turkey, 12 – 15 March Patient led advocacy is vital in...

How will 2015 be a defining year for the Alliance?

28 Feb 2015 Bridie Taylor

Viral hepatitis is a global killer with alarming mortality rates, yet an increased global commitment to tackling the disease and ground-breaking new...

How does the Alliance really represent hepatitis patients?

28 Feb 2015 Bridie Taylor

The World Hepatitis Alliance prides itself as the true voice of hepatitis patients living all over the world. All our work is overseen by an...

What is the future for hepatitis treatments? And how we can fund hepatitis programmes?

28 Feb 2015 Bridie Taylor

Discussions around hepatitis are dominated by the pioneering new treatments rapidly transforming the landscape and the ensuing heated discussions...

WHA in official relations with WHO: What does this mean for you?

28 Feb 2015 Bridie Taylor

Fundamental to our ability to influence global hepatitis policy and bring about real change in the world of hepatitis is our relationship with the...

Need some inspiration for action? : Initiatives from WHA members

28 Feb 2015 Bridie Taylor

Together our voices are stronger and united we can tackle this global killer! The World Hepatitis Alliance is fortunate enough to be made up of...

Assisting WHO in the development of a global strategy

31 Jan 2015 Bridie Taylor

World Health Organization Member States have urged WHO to develop a comprehensive global strategy on hepatitis. To assist in the development of this...

World Hepatitis Alliance’s ever-growing membership base

31 Jan 2015 Bridie Taylor

Central to the success of the World Hepatitis Alliance are our member groups around the world. To stimulate political interest in and action on...

Joining expert committees to promote harm reduction

31 Jan 2015 Bridie Taylor

Harm reduction policies are proven to save lives. Globally, as many as 67% of People Who Inject Drugs (PWIDs) have hepatitis C and an additional 8.4...

Promoting screening among high risk communities with new multi-lingual tool

31 Jan 2015 Bridie Taylor

In Europe, migrant populations are disproportionally affected by hepatitis B and C. Crucial to reducing the burden is improving screening among these...

Supporting the development of national action plans in South America

31 Jan 2015 Bridie Taylor

Government commitment to comprehensive national action plans is key to addressing the burden of viral hepatitis. To support the development of...

Exploring new treatment developments and innovative ways to finance healthcare

31 Jan 2015 Bridie Taylor

New therapeutic developments are revolutionising the way hepatitis is treated. But with a global lack of funding, how can these pioneering new drugs...

Pages

News from infohep

Rapid hepatitis C treatment leads to high cure rate in young people who inject drugs

12 Oct 2021 Keith Alcorn
A simplified, same-day treatment model led to a higher cure rate compared with usual care for young people who inject drugs, according to research...

People with HIV taking newer antiretrovirals at higher risk of fatty liver disease

8 Oct 2021 Keith Alcorn
People with HIV were more likely to develop fatty liver disease if they took antiretroviral treatment that contains an integrase inhibitor or...

People with diabetes or high alcohol consumption at higher risk of late hepatitis C diagnosis

24 Sep 2021 Keith Alcorn
People with diabetes and those with hazardous alcohol intake were significantly more likely to remain undiagnosed with hepatitis C and present with...

Testing COVID-19 patients for viral hepatitis does not detect numerous undiagnosed cases

19 Sep 2021 Keith Alcorn
Screening people admitted to hospital with COVID-19 for hepatitis C or hepatitis B does not lead to detection of a large number of undiagnosed...

Ultra-short course treatment for hepatitis C: high failure rate but does not compromise second-line treatment

13 Sep 2021 Keith Alcorn
Ultra-short treatment courses tailored to a person's pre-treatment viral load deliver lower cure rates than 8-week treatment courses, but...

Short stay in prison increases the risk of hepatitis C for people who use drugs

3 Sep 2021 Keith Alcorn
People who use drugs were over 50% more likely to acquire hepatitis C between 2004 and 2019 if they spent even a brief period in prison, a...

Japanese study shows benefits of treating hepatitis C early

24 Aug 2021 Keith Alcorn
Curing hepatitis C in people with mild fibrosis by the age of 50 reduces their risk of death to the same level as the rest of the population,...

US CDC recommends third dose of Moderna or Pfizer COVID-19 vaccines for organ transplant recipients

16 Aug 2021 Keith Alcorn
People who have undergone a solid organ transplant and who received the Pfizer or Moderna COVID-19 vaccines should receive a third dose, the US...

High hepatitis C cure rate in Thai study of community-based treatment

9 Aug 2021 Keith Alcorn
Community-based testing and treatment for HIV and hepatitis C achieved high hepatitis C cure rates in Thailand, results from the Thai C-FREE study...

Hepatitis C virtually eliminated in people with HIV in the Netherlands

23 Jul 2021 Keith Alcorn
Hepatitis C has been almost eliminated as a health problem for people living with HIV in the Netherlands due to direct-acting antiviral treatment...